University of Colorado Cancer Center member institution, Colorado State University, which has noted expertise in understanding radiation as both a cause and a cure for cancer, is co-hosting a scientific meeting on the University of Colorado Anschutz Medical Campus in Aurora this week called “Photon, Proton, and Carbon Ion Radiotherapy: Advances in Basic, Translational, and Clinical Research.”
COXEN, a computer model that suggests treatment based on cancer genetics, is being tested in a new clinical trial, here at the CU Cancer Center and nationally via clinical sites of the Southwest Oncology Research Group.
“Treatments Waiting to be Discovered” Inside New Database
August 5, 2014 · No comments
University of Colorado Cancer Center database, multiMiR, allows researchers to search microRNA, gene, disease, and drug interactions.
4 Lessons for Effective, Efficient Research in Health Care Settings
July 15, 2014 · Comments Off
CU Cancer Center study shows that by taking into account the real-world constraints of the systems in which providers deliver care and patients receive it, researchers can help speed results, cut costs, and increase chances that recommendations from their findings will be implemented.
Study of Dermatology on YouTube Shows New Ways Science Reaches Public
July 9, 2014 · Comments Off
A CU Cancer Center study published in the Dermatology Online Journal shows that YouTube also allows researchers, journals, and health advocates to connect directly with the public on topics of skin cancer and prevention.
Study Shows Tale of Two Prognoses in Pediatric Brain Tumor, Pilocytic Astrocytoma
June 2, 2014 · Comments Off
Research presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 used a newly designed test for "K:B gene fusion" to show that point mutations lead to a more dangerous form of the disease than does K:B fusion.
DREAM Project Crowdsources Answer to Cancer Cell Drug Sensitivities
June 2, 2014 · Comments Off
A study published June 1 in the journal Nature Biotechnology describes the results of an open challenge to predict which breast cancer cell lines will respond to which drugs, based only on the sum of cells’ genomic data. The winning entry, from the Helsinki Institute for Information Technology, was 78 percent accurate in identifying sensitive versus resistant cell lines, and was one of 44 algorithms submitted by groups from around the world.
Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing
June 1, 2014 · Comments Off
Aisner suggests close communication, systems approaches, keeping special requests to a minimum, and patience on the part of requesting oncologists. The key, she says, is writing new institutional protocols to keep pace with the new reliance on molecular testing.
ALK, ROS1 and now NTRK1: Study Shows Prevalence of New Genetic Driver in Lung Cancer
May 31, 2014 · Comments Off
Study reports the prevalence of the NTRK1 mutation in an unselected population of 450 lung cancer samples, with >1% percent of patients testing positive. This and other work from Dr. Doebele’s group forms the basis of a phase 1 clinical trial targeting NTRK1 mutations in advanced solid tumors (NCT02122913).
NTRK1: a new oncogene and target in lung cancer
May 31, 2014
Provider Portrait: Medicine and Music Make a Perfect Match
August 26, 2014 · No comments
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
I posted 51 photos on Facebook in the album "Dinner In White 2014" fb.me/1BrJMvx4U
"Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than... fb.me/2FmpIrmIm
Learn about how "dogs can be a cancer patients best friend". fb.me/6N8lB8nGt